Skip to main content
. 2022 Aug 28;8(9):e10416. doi: 10.1016/j.heliyon.2022.e10416

Table 3.

Univariate and multivariate Cox analysis (Overall Survival) of prognostic covariates in patients with pancreatic cancer.

Characteristics Total(N) Univariate analysis
Multivariate analysis
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
T stage (T3 & T4 vs. T1 & T2) 176 2.023 (1.072–3.816) 0.030 1.057 (0.516–2.166) 0.879
N stage (N1 vs. N0) 173 2.154 (1.282–3.618) 0.004 1.524 (0.818–2.838) 0.184
M stage (M1 vs. M0) 84 0.756 (0.181–3.157) 0.701
Radiation therapy (Yes vs. No) 163 0.508 (0.298–0.866) 0.013 0.430 (0.227–0.813) 0.009
Primary therapy outcome (PR & CR vs. PD&SD) 139 0.425 (0.267–0.677) <0.001 0.524 (0.315–0.871) 0.013
Gender (Male vs. Female) 178 0.809 (0.537–1.219) 0.311
Race (White vs. Asian & Black or African American) 174 1.161 (0.582–2.318) 0.672
Age (>65 vs. ≤65) 178 1.290 (0.854–1.948) 0.227
Residual tumor (R1 & R2 vs. R0) 164 1.645 (1.056–2.561) 0.028 1.503 (0.887–2.546) 0.130
Histologic grade (G3 & G4 vs. G1 & G2) 176 1.538 (0.996–2.376) 0.052
Anatomic neoplasm subdivision (Other vs. Head of Pancreas) 178 0.417 (0.231–0.754) 0.004 0.559 (0.265–1.178) 0.126
PLAAT4 (High vs. Low) 178 1.943 (1.279–2.953) 0.002 1.806 (1.080–3.020) 0.024